Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Medecine Sciences : M/S|December 24, 2016
[The role of intestinal microbiota in the response to anti-tumor therapies]Marie Vétizou, Romain Daillère, Laurence ZitvogelBiologie Aujourd'Hui|July 7, 2017
[Gut microbiota and efficacy of cancer therapies]Marie Vétizou, Romain Daillère, Laurence ZitvogelThe Journal of Experimental Medicine|December 17, 2025
Bringing natural killer cells to the clinic: Opportunities beyond cancerMarjorie Cayatte, Valentin Picant, Marie Vétizou, et al.Science Translational Medicine|January 23, 2015
Cancer and the gut microbiota: an unexpected linkLaurence Zitvogel, Lorenzo Galluzzi, Sophie Viaud, et al.Oncoimmunology|February 16, 2017
Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiotaJonathan M Pitt, Marie Vétizou, Ivo Gomperts Boneca, et al.Cancer Research|July 31, 2016
Fine-Tuning Cancer Immunotherapy: Optimizing the Gut MicrobiomeJonathan M Pitt, Marie Vétizou, Nadine Waldschmitt, et al.Cancer Research|September 12, 2015
Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor CellsSanam Peyvandi, Stéphanie Buart, Boubekeur Samah, et al.Immunity|June 23, 2016
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic FactorsJonathan M Pitt, Marie Vétizou, Romain Daillère, et al.The Journal of Clinical Investigation|February 9, 2016
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanomaNicolas Jacquelot, David P Enot, Caroline Flament, et al.Cell Research|January 14, 2015
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25Dalil Hannani, Marie Vétizou, David Enot, et al.Pageof 2